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Challenges in reducing depression-related mortality in cardiac
populations: cognition, emotion, fatigue or personality?
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in Ireland, Dublin, Ireland; bDepartment of Epidemiology & Public Health Medicine, Royal
College of Surgeons in Ireland, Dublin, Ireland
(Received 17 July 2007; final version received 25 February 2008)
Depression is associated with increased morbidity and mortality in cardiac
patients post-event, however treatment of psychological symptoms has failed to
reduce cardiovascular risk. We explore depression and related constructs in terms
of construct overlap and intervention potential. Certain depressive symptoms
may be more important than others for increasing risk. Depressive cognitions
may have lesser importance than somatic symptoms, however there is potential
for designing interventions based on distorted illness perceptions. Somatic
depressive symptoms and vital exhaustion are associated with increased risk.
However, these symptoms may be more indicative of cardiovascular disease
severity. A global tendency towards negative affectivity could account for the
associations seen with negative affect states, with those of Type D personality
demonstrating especially high levels of risk for morbidity/mortality. Positive
emotion is associated with better outcomes, and could provide clues of how to
intervene with negative emotion. Construct overlap and a dearth of theoretically
based studies remain significant challenges. Future research needs to encompass
all relevant variables to identify the key symptoms or symptom constellations that
increase cardiovascular risk. A more sophisticated understanding of these issues
can lead to more precise pinpointing of the ‘cardiotoxic’ aspects of psychological
status, and ultimately to more refined interventions.
Keywords: coronary heart disease; depression; mortality; intervention;
personality; positive emotion
Background
Depression is more common in medical patients compared to the general
population. For patients with myocardial infarction (MI), the prevalence of
depression post-event is generally reported as more than double that of comparable
general population samples (i.e., 15.5!31.1% versus 3.0!7.3%) (Jacobi et al., 2005;
Lett et al., 2004; Thombs et al., 2006). While this higher prevalence of depression
was initially regarded as an epiphenomenon ! an understandable and transient
response to a life-threatening event ! there is now an increasing realisation not only
that depression may have been present prior to the cardiac event, but that depression
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may actually be important in the aetiology and prognosis of coronary heart disease
(CHD).
Depression has been found to be a strong predictor both of the development of
CHD and of its subsequent prognosis (Barth, Schumacher, & Herrmann-Lingen,
2004; Lett et al., 2004; van Melle et al., 2004). Several reviews and meta-analyses
have concluded that depression not only predicts the development of CHD in
initially healthy persons (Rugulies, 2002; Wulsin & Singal, 2003), but in those with
established CHD, post-event depression is associated with a relative risk of 1.5"2.5
for recurrent fatal or non-fatal events (Lett et al., 2004; van Melle et al., 2004). The
majority of these studies have been conducted on post-coronary inpatients with acute
coronary syndrome (ACS; MI or unstable angina). Thus, a call has been made for
depression to be recognised as one of the most important potentially modifiable
prognostic factors in persons with established CHD (Rumsfeld & Ho, 2005).
However, although the treatment of depression in post-coronary patients has
reduced the prevalence of detected depression, it has not demonstrated a reduction
in subsequent morbidity or mortality. Adding to the non-significant findings of
SADHART and ENRICHD (Berkman et al., 2003; Glassman et al., 2002;
Lesperance et al., 2007; van Melle et al., 2007), the recent MIND-IT trial also
produced no effect (van Melle et al., 2007). MIND-IT evaluated the effectiveness of
anti-depressants in a randomised controlled trial of over 2000 patients with MI (van
Melle et al., 2007). Patients were assessed for depression with diagnostic interviews
in-hospital and at three, six, nine and 12 months post-MI. Cardiac events up to 18
months post-MI were assessed. Treating depression did not improve cardiac
endpoints (14% in intervention versus 13% control), depression or quality of life
measures, and approximately one-third of patients continued to be depressed 18
months post-event. A failure to even reduce depression scores was important, but
also echoes some results of the CREATE trial (Lesperance et al., 2007). CREATE
demonstrated that short-term treatment of depression with interpersonal psy-
chotherapy was not efficacious in persons with coronary artery disease (although
use of a selective serotonin reuptake inhibitor was effective, especially in those with
prior depression). These findings further increase the difficulty of intervening with
depression in CHD patients ! not only are the established depression treatments
unsuccessful for reducing depression, they also fail to reduce cardiovascular risk.
Thus, vanMelle et al. (2007) echoed the call of previous researchers who question the
validity and homogeneity of depression in ACS (Frasure-Smith & Lesperance, 2003;
van Melle et al., 2007).
The failure of these trials suggests that models of depression based on psychiatric
disorder, as is the pattern to date, may not be optimal for the detection and
management of depression in CHD populations. Alternative psychological theories
of depression, which have yet to be assessed in CHD patients, may point the way to
more successful interventions (Davidson, Rieckmann, & Lesperance, 2004). The
psychiatric approach, which considers depression as a distinct disorder, may also be
less useful than an approach which considers the spectrum of well-being, running
from depression to positive health (Keyes, 2004). Depression certainly exhibits a
dose!response relationship with CHD morbidity with an observable gradient of risk
across the spectrum of depressive symptoms (Bush et al., 2001; Doyle, McGee, De
La Harpe, Shelley, & Conroy, 2006; Lett et al., 2004; Rugulies, 2002; Wulsin &
Singal, 2003). To date, however, few studies have examined the positive end of the
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spectrum: a link between well-being and reduced risk of cardiovascular events. Blazer
and Hybels (2004) and Ostir, Markides, Peek and Goodwin (2001a) are two studies
that have demonstrated an association between positive affect and decreased risk.
An excellent paper by Davidson et al. (2004) outlines how theories of depression
may influence the development of cardiovascular disease. The authors suggest that
the usefulness (or otherwise) of various psychological treatments for depressive
symptoms post-event will differ depending on the proximal cause of depression in
each patient. The identification of proximal causes of depression may indicate a
difference between those patients with and those patients without spontaneously
remitting depression. For example, those patients with cognitive distortions, low
positive reinforcement and interpersonal problems are more likely to stay depressed
post-event than those who do not display any of these vulnerabilities (Davidson et
al., 2004). Thus, treatment could focus on those with non-remitting depression. The
interested reader is referred to the original paper for a more in-depth discussion. The
present article expands on these ideas by incorporating research on other related
psychological constructs that also predict morbidity/mortality in CHD patients
when assessed during or after the acute hospitalisation phase. Research on vital
exhaustion and Type D personality has also yielded significant results in risk
prediction post-event (Appels, 2004; Denollet, 2000; Denollet & Van Heck, 2001;
Pedersen & Denollet, 2003), whereas modifying distorted illness perceptions has
been shown to reduce angina re-occurrence in patients with MI (Petrie, Cameron,
Ellis, Buick, & Weinman, 2002). The extent of overlap between depression and these
variables has not been consistently established, and thus previous findings on
depression may be limited by not assessing these alternative paradigms. Constructs
are defined in Table 1, along with the details of prognostic studies in those with
established CHD (examples only are given for depression, as this has been
systematically reviewed recently, e.g., Barth et al. (2004), Frasure-Smith and
Lesperance (2006) and Nicholson, Kuper, and Hemingway (2006), but systematic
searches were conducted for the remaining constructs). In an accompanying editorial
to the MIND-IT trial, Carney and Freedland (2007) called for research which could
refine our understanding of depression in CHD patients, and research which could
pinpoint exact aspects of depression which have harmful effects. Other authors have
concluded that a more global measure of negative affectivity could be a more
appropriate conceptualisation, and highlight significant overlap between many
negative emotions which are currently considered separately in the literature (Suls
& Bunde, 2005). Thus, including these related constructs will highlight the most
appropriate aspects that can inform interventions to reduce cardiovascular
morbidity/mortality post-event. This paper provides a brief outline of the following
areas in relation to CHD patients: cognitive distortions (depression and illness
perceptions), positive emotion, vital exhaustion (fatigue), Type D personality. This
paper briefly addresses the following: (1) a description of each construct; (2) how the
construct relates to depression and/or cardiovascular outcomes; and (3) interven-
tions derived from each model and their (potential) treatment for depression (and
possible impact on subsequent cardiovascular outcomes).
We do not claim that the presented concepts represent the full spectrum of
negative affect in CHD patients, but the overlap among these constructs provides a
starting point to integrate the literature.
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Table 1. Definitions of depression and related constructs, and examples of studies investigating associations with cardiovascular morbidity and/or
mortality in samples with established CHD.
Construct Definition Study examples Study design
Effect size (adjusted
analysis unless stated
otherwise) Measurement tool Comments
Depression Major Depressive Disorder
(DSM-IV): one of either
depressed mood or anhe-
donia for two weeks, along
with at least four of the
following symptoms:
weight/appetite loss/gain;
insomnia/hypersomnia;
psychomotor retardation or
agitation; fatigue; feelings
of worthlessness or guilt;
difficulty concentrating;
suicidal ideation
Barth et al.
(2004)
Meta-analysis of 20
studies of CHD
patients, up to 15
years follow-up
HR#1.76 for
mortality two years
post-event (OR#ns for
mortality within two
years post-discharge)
Not applicable Reported that
either interview or
questionnaire were
equivalent predictors
of outcomes
de Jonge, Ormel,
et al. (2006)
2466 MI patients
followed for mean 2.5
years
HR#3.91 for somatic/
affective symptoms
only
BDI (21-item). Factor
analysis divided BDI
into cognitive/affective,
somatic/affective and
appetitive symptoms
Association
significant when
controlling for other
symptoms of
depression
Frasure-Smith et
al. (1995)
222 MI patients
followed for 18 months
OR#ns for DIS
interview (in adjusted
analysis) (OR#6.64
(questionnaire)
Modified National
Institute of Mental
Health DIS (BDI) (21
item)
BDI scale was
significant predictor
of outcomes at 18
months, but DIS was
not
Nicholson et al
(2006)
Meta-analysis of 54
studies (n#146,538) of
aetiology and prognosis
RR#1.53 for eight
adjusted studies,
unadjusted RR#1.80
for 34 prognostic
studies
Not applicable Evidence of
publication bias.
Non-adjusted results
often published, and a
substantial attenua-
tion of risk seen after
adjustment for left
ventricular function
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Table 1 (Continued)
Construct Definition Study examples Study design
Effect size (adjusted
analysis unless stated
otherwise) Measurement tool Comments
van Melle et al.
(2004)
Meta-analysis of 6367
MI patients (3343
patients from studies
with cardiac mortality
as outcome) followed
for average 13.7 months
OR#2.59 (unadjusted)
for cardiac mortality
Not applicable Association with
mortality was more
pronounced in the
older studies (OR,
3.22 before 1992) than
in the more recent
studies (OR, 2.01
after 1992). Reported
that either interview
or questionnaire were
equivalent predictors
of outcomes
Vital exhaustion Feelings of excess fatigue,
energy loss, irritability and
demoralisation, which ap-
pear unrelated to (cardiac)
illness severity
Irvine et al.
(1999)
671 MI patients
followed for two years
RR#1.31 (per unit
increase on scale) for
association between
fatigue and sudden
cardiac death
Assessed fatigue with
Yale scale (not vital
exhaustion), and
depression (BDI)
Depression also
significant predictor,
but inclusion of
fatigue attenuated the
association of depres-
sive symptoms with
SCD
Koertge et al.
(2002)
110 women with MI
followed for five years
HR#2.24 for cardiac
death for those scoring
above median on vital
exhaustion
MQ (18 items). This
version has more
depression items than
later versions
Women assessed 3!6
months post-MI.
Results adjusted for
coronary stenosis and
chest pain severity
Kop, Appels,
Mendes de Leon,
de Swart, and
Bar (1994)
127 PCI patients
followed for 1.5 years
OR#2.34 for cardiac
morbidity/mortality
MQ (21 items) Other psychological
variables not reported
Mendes de Leon,
Kop, de Swart,
Bar, and Appels
(1996)
149 PCI patients
followed for 1.5 years
RR#2.57 for recurrent
cardiac events
MQ (21 item) Anger was also
predictive of events,
but composite of
anger and vital
exhaustion was most
predictive
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Table 1 (Continued)
Construct Definition Study examples Study design
Effect size (adjusted
analysis unless stated
otherwise) Measurement tool Comments
Pedersen,
Denollet,
Daemen, et al.
(2007)
534 PCI patients
followed for two years
HR#2.73 for cardiac
events/death for total
vital exhaustion score,
but fatigue items were
non-significant when
analysed independently
MQ (21 item) Divided MQ into
fatigue, depression
and hopelessness.
Depression (adjusted
HR#2.69) was
cardiotoxic, with
hopelessness
(adjusted HR#3.36)
item most significant
Type D
personality
Tendency to experience
increased negative distress
and to then inhibit the
expression of these negative
emotions in social settings,
for fear of disapproval or
rejection
Denollet et al.
(1996)
303 CHD patients
followed for 6!10 years
OR#4.1 for mortality Composite personality
questionnaire assessing
social inhibition and
negative affectivity
analysed (using median
split) via theoretical
and statistical proce-
dures
Type D predictive of
cardiac and non-
cardiac mortality.
Type D associated
with depression
Denollet and
Brutsaert (1998)
87 MI patients followed
for 6!10 years
RR#4.7 for cardiac
events
Type D assessed by
combination of various
scales (using 75th
percentile as cut-off for
anxiety and anger
scales).
Specific emotions
(depression, anxiety,
anger) did not add to
the predictive power
of Type D
Denollet et al.
(2000)
319 cardiac patients
followed for five years
OR#8.9 for cardiac
death or non-fatal
myocardial infarction
DS16 (16-item scale
assessing Type D
personality), ZDS and
Dutch version of STAI
assessed depression
and anxiety
Depression and
anxiety non-
significant in
multivariate analysis
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Table 1 (Continued)
Construct Definition Study examples Study design
Effect size (adjusted
analysis unless stated
otherwise) Measurement tool Comments
Denollet,
Pedersen, Ong,
et al. (2006) and
Pedersen et al.
(2004)
875 PCI patients
followed for nine
months
HR#1.92 for major
adverse cardiac event in
those with high
negative affectivity and
high inhibition (Type
D) only. OR#5.31 for
MI/mortality
DS14 (14-item scale
assessing Type D
personality). HADS
(7-item depression and
seven-item anxiety
scales) assessed
negative affect (anxiety
and depression). Scales
completed six months
post-PCI
Negative affect did
not explain the
association with
increased risk
Denollet, Pedersen,
Vrints, and
Conraads (2006)
337 CHD patients
followed for five years
OR#2.9 for cardiac
death, MI or
revascularisation
DS16, GHQ (12-item) Controlled for
psychological stress
symptoms (GHQ)
Pedersen,
Denollet, Ong, et
al. (2007)
358 PCI patients treated
with drug-eluting stents
HR#2.61 for cardiac
morbidity or mortality
DS14 (14 items) Controlled for history
of coronary artery
disease, multivessel
disease, diabetes,
hypercholesterolemia,
hypertension, renal
impairment and
smoking
Positive affect Positive moods or emotions
characterised by
engagement and energy
(although no fixed
definition in the literature,
and measurement tools
vary widely and may
include optimism)
Barefoot et al.
(2000)
1250 patients with
coronary artery disease
diagnosed by coronary
angiography
HR#1.10 (ns) for
(reverse-scored)
well-being, adjusted for
negative affect and
somatic symptoms
Zung Self-rating
Depression Scale
(20-item), factor
analysed into
well-being, negative
affect, somatic and
appetite symptoms.
Hopelessness assessed
by one MMPI item
Negative affect
(HR#1.30),
continued to predict
mortality in adjusted
analysis, but other
constructs did not.
Marginal significant
for hopelessness item
(HR#1.40, p#0.06)
when controlling for
negative affect in
analysis of 867
patients
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Table 1 (Continued)
Construct Definition Study examples Study design
Effect size (adjusted
analysis unless stated
otherwise) Measurement tool Comments
Brummett et al.
(2005)
866 PCI patients
followed for mean 11.4
years
HR#0.8, but HR#ns
when controlling for
depression
NEO-PI eight-item
positive emotion and
eight-item depression
scales
Depression remained
significant when
controlling for
positive emotion
Note: BDI, Beck Depression Inventory; CES-D, Centre for Epidemiological Studies Depression Scale; DIS, Diagnostic interview schedule; DS14, DS16, Type D
personality scales; DSM-IV, Diagnostic and Statistical Manual for Mental Disorders ! IV; GHQ, General Health Questionnaire; HADS, Hospital Anxiety and
Depression Scale; HR, hazard ratio; IPQ, Illness Perception Questionnaire; MIVE, Maastricht interview for vital exhaustion; MQ, Maastricht Questionnaire (assesses
vital exhaustion); NEO-PI, Neuroticism, openness, extraversion personality inventory; ns, non-significant; OR, Odds ratio; PCI, percutaneous coronary intervention;
RR, relative risk; STAI, State-trait anxiety inventory; ZDS, Zung Depression Scale.
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Cognitions ! depression
Much of the research into the association between depression and CHD has been
atheoretical, providing no clear insight into how interventions may be derived from
the findings. Few studies have been conducted on the antecedents of depression in
CHD patients. There also remains the question of whether depression itself
influences outcomes, or whether outcomes are influenced by some other aspect of
somaticised symptoms of disease severity (Lane, Carroll, Ring, Beevers, & Lip, 2000;
Lane, Carroll, Ring, Beevers, & Lip, 2002; Lane, Lip, & Carroll, 2004). The proximal
causes of depression in post-coronary patients may influence the development of
CHD, the usefulness of a particular treatment, and the potential for spontaneous
remission in this population (Davidson et al., 2004).
Cognitive theory of depression
The cognitive model is one of the most commonly utilised models of depression
(Beck, 1991, 2005; Kanter, Callaghan, Landes, Busch, & Brown, 2004). It evolved
through an observation of depressed patients’ verbalisation of thoughts. Beck (1991,
2005) and Beck, Rush, Shaw, and Emery (1979) noted that depressed patients had
various distorted thoughts and beliefs, and that negative mood was usually a
consequence of these thoughts. Cognitive theory forms a model where distorted self-
concepts (which may be latent) determine personal meaning in several situations, but
increase vulnerability to depression. Stressful life events can then trigger depressive
episodes.
Associations with depression and CHD
Support for this theory is seen in a large body of research which has demonstrated
that vulnerable individuals process information dysfunctionally (Alloy et al., 2000;
Beck et al., 1979; Dobson & Ottenbreit, 2004; Ingram, Odom, & Mitchusson, 2004).
Cognitive models of depression have been investigated in cardiac patients (Berkman
et al., 2003; Carney et al., 2004; de Jonge, Ormel, et al., 2006; Dijkstra et al., 2002;
Rieckmann et al., 2006; Roberts, 1989; Shnek, Irvine, Stewart, & Abbey, 2001).
Rieckmann et al. (2006) demonstrated that mildly to moderately/severely depressed
patients with ACS had significantly higher levels of dysfunctional attitudes
compared to non-depressed ACS patients. Although depression has been associated
with morbidity and mortality following CHD, subsequent research questioned
whether cognitive symptoms of depression were associated with mortality, or
whether only somatic symptoms predicted outcomes (Table 1) (de Jonge, Ormel, et
al., 2006; Doyle et al., 2006). Furthermore, there is also evidence to suggest that
symptoms of depression in post-MI patients are both quantitatively and qualitatively
different from symptoms observed in psychiatric patients, with cardiac patients
showing fewer distorted cognitions (Martens et al., 2006).
Interventions
Cognitive therapy assumes that thought precedes mood, and treatment enables
patients to correct false self-beliefs that lead to depressive moods or behaviours
(Beck, 1991; Beck et al., 1979). Patients learn to substitute healthier thoughts for
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distorted thoughts, and mood improves. Cognitive therapy is a well-established and
successful treatment for depression (Butler, Chapman, Forman, & Beck, 2006).
Subsequent manifestations of cognitive therapy also included some behavioural
principles, evolving to cognitive-behavioural therapy (CBT) (Kanter et al., 2004).
The ENRICHD trial attempted to determine whether mortality and recurrent
infarction were reduced by treating depression and low perceived social support with
CBT (supplemented with antidepressants when indicated) (Berkman et al., 2003).
There was no significant difference in morbidity or mortality between usual care and
intervention groups over an average follow-up of 29 months, even though a
significant reduction in depressive symptoms was seen. The authors concluded
that a substantial improvement in depression in the control group could have hidden
the effects of the intervention. However, alternative explanations are also plausible.
The spontaneous remission of depressive symptoms in the control group may, for
example, indicate that much of the depression measured in ENRICHD was a
relatively transient response to a major negative life event which resolved
spontaneously over time ! more akin to adjustment disorder than major depression,
minor depression or dysthymia (Frasure-Smith & Lesperance, 2003). Furthermore,
since major depressive disorder is a heterogeneous disease, it may be that only a
proportion of the treatment group benefited from improved cardiovascular outcomes
(i.e., a sub-group for whom CBT was most appropriate, other sub-groups may have
benefited from interpersonal therapy or operant therapy) (Davidson et al., 2004).
Indeed, Rieckmann et al. (2006) demonstrated that depressed ACS patients exhibited
cognitive, interpersonal and behavioural vulnerabilities to depression, and that these
vulnerabilities were independently associated with depression. Therefore, the trial
would not have been powered to find the difference in the sub-group for which it was
most suited. Also, since cognitive depressive symptoms are not associated with
subsequent mortality (de Jonge, Ormel, et al., 2006; Doyle et al., 2006), it is perhaps
unsurprising that the treatment of these symptoms through CBT had no impact on
cardiovascular outcomes.
Cognitions ! illness
Self-regulatory model (SRM) of illness perceptions
Another area of cognitive distortions (related to illness) has shown promise in the
development of effective interventions, and is based on the self-regulatory model
(SRM) of illness perceptions (Leventhal, Diefenbach, & Leventhal, 1992; Leventhal,
Meyer, & Nerenz, 1980; Weinman & Petrie, 1997; Weinman, Petrie, Moss-Morris, &
Horne, 1996). This theory postulates that individuals are active problem solvers, who
make cognitive and emotional representations of illness in order to make sense of its
potential threat to their health, and then determine how to respond (Fortune,
Richards, Griffiths, & Main, 2004; Horne & Weinman, 1999; Leventhal, Leventhal,
& Cameron, 2001; Moss-Morris et al., 2002). These coping behaviours are then
reappraised in terms of efficacy (e.g., reducing symptoms) along with the illness
representation. The model thus combines three stages and a continuous feedback
circuit (Broadbent, Petrie, Main, & Weinman, 2006; Horne, 1997; Leventhal et al.,
2001). Illness representations are made up of several components (see Table 1).
‘Distorted’ or incorrect illness perceptions may have implications for how patients
175
180
185
190
195
200
205
210
215
10 F. Doyle et al.
C:/3B2WIN/temp files/RHPR304800_S100.3d[x] Tuesday, 25th March 2008 18:35:55
UN
CO
RR
EC
TE
D P
RO
OF
behave during secondary prevention. For example, if a patient believes that a virus
caused their heart attack (despite repeated explanations otherwise), they may be less
likely to adhere to anti-hypertensive medication.
Associations with depression ! theoretical commonalities
There are potential theoretical links between depression and illness perceptions.
First, diagnosis with a life-threatening illness is a common antecedent of depression,
and of course may be the cause of new or evolving illness perceptions, as with CHD
patients. Second, there is the possibility that both depression and illness perceptions
are evolving not only from the same threatening life event, but also at the same time,
each influencing the other (e.g., depressed patients are known to catastrophise illness
symptoms and demonstrate poor psychological adjustment (Moss-Morris, Petrie, &
Weinman, 1996; Petrie, Moss-Morris, & Weinman, 1995)). Illness representations
can be formulated and modified at either or both of two stages of illness appraisals:
disease occurrence (cause) or disease management (coping) (Schiaffino & Cea, 1995;
Weinman et al., 1996). Therefore, potential depressive-related distortions could
occur during either or both of these phases. Third, it is possible that people who
blame themselves for negative events will also blame themselves for their CHD (a
cognition that could be reinforced by explanations of lifestyle factors as being key
risk factors for CHD). Indeed, some researchers have stated that individual
differences in adjustment to illness can be better explained by a single dimension !
maladaptive thinking ! than by specific illness cognitions (Evers et al., 2001).
Research has also demonstrated that depression and illness perceptions predict
similar heath behaviours in patient populations, such as non-adherence to medica-
tion and non-attendance at cardiac rehabilitation programmes (French, Cooper, &
Weinman, 2006; Horne & Weinman, 1999; Ziegelstein et al., 2000). The items of the
Brief Illness Perception Questionnaire (IPQ) (Broadbent et al., 2006) are listed in
Table 2, alongside symptoms of depression assessed by various scales and interviews,
including the diagnostic classifications of DSM-IV and ICD-10. Table 2 demon-
strates potential overlap between the constructs outlined in this paper. In the case of
illness perceptions, it could be argued that up to five of the nine items assess
depressive cognitions (including the symptom of depressed mood). Thus, potential
interactions between illness perceptions and depression deserve critical investigation.
Associations with depression ! research findings
Researchers have shown significant associations between various illness perceptions
and negative affectivity (Broadbent et al., 2006; Moss-Morris et al., 2002). Other
studies have specifically related distorted illness perceptions to depression in CHD
(French, Lewin, Watson, & Thompson, 2005; Grace, Krepostman, et al., 2005).
Furthermore, depression as an illness can also be considered within the SRM.
Fortune et al. (2004) studied the SRM of depression in a convenience sample of 101
women with current or past depression. Beck Depression Inventory (BDI) scores
correlated significantly with scales of the IPQ (which assesses the SRM (Weinman et
al., 1996)), and the IPQ was also able to discriminate between women who were and
those who were not depressed. In terms of IPQ subscales, currently depressed women
had a stronger depression identity, a more chronic timeline, less perceived control
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Table 2. Comparison of overlapping symptoms of various constructs by questionnaire/interview.
Symptom
type
assessed by
interviews
or scales
DSM-IV
Major
Depressive
Disorder
(American
Psychiatric
Association,
2000)
ICD-10 (Mild,
moderate or
severe
depressive
episode) (World
Health
Organisation,
1993)
Maastricht
Interview for
Vital
Exhaustion
(Meesters &
Appels, 1996)
BDI!II (Beck
et al., 1996)
Center for
Epidemiological
Studies-
Depression
scale (CES-D)
(Radloff, 1977)
Hospital
Anxiety and
Depression
Scale
(depression
subscale)
(Zigmond &
Snaith, 1983)
Brief-Illness
Perception
Questionnaire
(Broadbent et
al., 2006)
Global Mood
Scale (positive
and negative
affect rated on a
five-point Likert
scale) (Denollet,
1993)
DS-14 (Type D
personality)
(Denollet, 2005)
Significant
depressed
mood
Significant
depressed
mood
Depressed
mood
(5) Do you feel
dejected? (20)
Do you
sometimes cry
or feel like
crying?
(1) Sadness.
(10) Crying
(3) I felt that I
could not
shake off the
blues even
with help from
my family or
friends. (6) I
felt depressed.
12) I was
happy. (17) I
had crying
spells. (18) I
felt sad
(6) I feel
cheerful
(8) How much
does your
illness affect
you
emotionally?
(e.g., does it
make you
angry, scared,
upset or de-
pressed?
(17) Cheerful (4) I often feel
unhappy. (7) I
take a gloomy
view of things.
(9) I am often in
a bad mood.
(13) I am often
down in the
dumps
Anhedonia Loss of in-
terest or
pleasure (an-
hedonia)
Loss of interest
and enjoyment
(anhedonia)
(15) Have you
noticed a de-
crease in your
sexual appetite
or a decrease in
the desire to
make love?
(4) Loss of
pleasure. (12)
Loss of
interest. (21)
Loss of
interest in sex
(16) I enjoyed
life
(2) I still enjoy
the things I
used to enjoy.
(4) I can laugh
and see the
funny side of
things. (10) I
have lost
interest in my
appearance.
(14) I can enjoy
a good book,
radio or TV
programme
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Table 2 (Continued)
Symptom
type
assessed by
interviews
or scales
DSM-IV
Major
Depressive
Disorder
(American
Psychiatric
Association,
2000)
ICD-10 (Mild,
moderate or
severe
depressive
episode) (World
Health
Organisation,
1993)
Maastricht
Interview for
Vital
Exhaustion
(Meesters &
Appels, 1996)
BDI!II (Beck
et al., 1996)
Center for
Epidemiological
Studies-
Depression
scale (CES-D)
(Radloff, 1977)
Hospital
Anxiety and
Depression
Scale
(depression
subscale)
(Zigmond &
Snaith, 1983)
Brief-Illness
Perception
Questionnaire
(Broadbent et
al., 2006)
Global Mood
Scale (positive
and negative
affect rated on a
five-point Likert
scale) (Denollet,
1993)
DS-14 (Type D
personality)
(Denollet, 2005)
Anergia,
fatigue or
energy loss
Loss of
energy or
fatigue
Reduced energy
leading to
increased
fatigue and
diminished
activity
(anergia)
(1) Do you
often feel tired?
(2) Do you feel
listless? (3) Do
you feel weak
all over or
without energy?
(6) Do you
sometimes have
the feeling that
your body is
like a battery
that is losing its
power? (7) Do
you have the
feeling that you
have not been
accomplishing
much lately? (8)
Do you ever
wake up with a
feeling of
exhaustion and
fatigue? (9) Do
you wake up
repeatedly
during the
night?
(15) Loss of
energy. (20)
Tiredness or
fatigue
(7) I felt that
everything I
did was an
effort. (20) I
could not get
‘going’
(8) I feel as if I
am slowed
down
(1) Wearied. (2)
Active. (3) Worn
out. (4)
Dynamic. (7)
Hard-working.
(8) Feeble. (9)
Lively. (10)
Physically weak.
(11) Listless. (12)
Tired. (13)
Enterprising.
(18) Fatigued.
(19) Weakened
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Table 2 (Continued)
Symptom
type
assessed by
interviews
or scales
DSM-IV
Major
Depressive
Disorder
(American
Psychiatric
Association,
2000)
ICD-10 (Mild,
moderate or
severe
depressive
episode) (World
Health
Organisation,
1993)
Maastricht
Interview for
Vital
Exhaustion
(Meesters &
Appels, 1996)
BDI!II (Beck
et al., 1996)
Center for
Epidemiological
Studies-
Depression
scale (CES-D)
(Radloff, 1977)
Hospital
Anxiety and
Depression
Scale
(depression
subscale)
(Zigmond &
Snaith, 1983)
Brief-Illness
Perception
Questionnaire
(Broadbent et
al., 2006)
Global Mood
Scale (positive
and negative
affect rated on a
five-point Likert
scale) (Denollet,
1993)
DS-14 (Type D
personality)
(Denollet, 2005)
Weight/
appetite
loss/gain
Substantial
weight/
appetite loss/
gain
Diminished
appetite
(18) Changes
in appetite
(2) I did not
feel like eating;
my appetite
was poor
Disturbed
sleep
patterns
Insomnia or
hypersomnia
Disturbed sleep (16) Changes
in sleep pat-
tern
(11) My sleep
was restless
Psychomotor
retardation/
agitation
Psychomotor
retardation/
agitation
Considerable
distress or
agitation,
retardation
(severe
depressive
episode)
(11) Agitation
Feeling
worthless,
guilty
Feelings of
worthlessness
or excessive
guilt
Reduced
self-esteem and
self-confidence.
Ideas of guilt
and
unworthiness
(14) Do you
have the feeling
these days that
you just do not
have what it
takes anymore?
(3) Past
failure. (5)
Guilty feelings
(6) Punishment
feelings. (7)
Self-dislike. (8)
Self-criticalness.
(14)
Worthlessness
(4) I felt that I
was just as
good as other
people. (9) I
thought my
life had been a
failure
(15) Insecure. (20)
Self-confident
14
F
.
D
oyle
et
al.
C
:/3B
2W
IN
/tem
p
files/R
H
P
R
304800_S
100.3d
[x]
T
u
esd
ay,
25th
M
arch
2008
18:35:55
UNCORRECTED PROOF
Table 2 (Continued)
Symptom
type
assessed by
interviews
or scales
DSM-IV
Major
Depressive
Disorder
(American
Psychiatric
Association,
2000)
ICD-10 (Mild,
moderate or
severe
depressive
episode) (World
Health
Organisation,
1993)
Maastricht
Interview for
Vital
Exhaustion
(Meesters &
Appels, 1996)
BDI!II (Beck
et al., 1996)
Center for
Epidemiological
Studies-
Depression
scale (CES-D)
(Radloff, 1977)
Hospital
Anxiety and
Depression
Scale
(depression
subscale)
(Zigmond &
Snaith, 1983)
Brief-Illness
Perception
Questionnaire
(Broadbent et
al., 2006)
Global Mood
Scale (positive
and negative
affect rated on a
five-point Likert
scale) (Denollet,
1993)
DS-14 (Type D
personality)
(Denollet, 2005)
Difficulty
concentrating
or indecisive-
ness
Diminished
ability to
think or
concentrate,
or
indecisiveness
Reduced
concentration
and attention
(16) Has it
become harder
lately to solve a
mental task or
problem that
requires much
concentration?
(17) Do you have
increasing
difficulty in
concentrating on
a single subject
for long?
(19)
Concentration
difficulty. (13)
Indecisiveness
(5) I had
trouble
keeping my
mind on what
I was doing
(5) Bright
Suicidal
ideation
Suicidal
ideation,
recurrent
thoughts of
death or
attempted
suicide
Ideas or acts of
self-harm or
suicide
(23) Do you
want to be dead
at times?
(9) Suicidality
Hopeless-
ness
Bleak and pes-
simistic views of
the future
(19) Do you
believe that you
have come to a
‘dead end? (22)
Did you
experience a
feeling of
hopelessness re-
cently?
(2) Pessimism (8) I felt
hopeful about
the future
(12) I look
forward with
enjoyment to
things
(2) How long
do you think
your illness will
continue? (4)
How much do
you think your
treatment can
help your
illness?
(6) Helpless
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Table 2 (Continued)
Symptom
type
assessed by
interviews
or scales
DSM-IV
Major
Depressive
Disorder
(American
Psychiatric
Association,
2000)
ICD-10 (Mild,
moderate or
severe
depressive
episode) (World
Health
Organisation,
1993)
Maastricht
Interview for
Vital
Exhaustion
(Meesters &
Appels, 1996)
BDI!II (Beck
et al., 1996)
Center for
Epidemiological
Studies-
Depression
scale (CES-D)
(Radloff, 1977)
Hospital
Anxiety and
Depression
Scale
(depression
subscale)
(Zigmond &
Snaith, 1983)
Brief-Illness
Perception
Questionnaire
(Broadbent et
al., 2006)
Global Mood
Scale (positive
and negative
affect rated on a
five-point Likert
scale) (Denollet,
1993)
DS-14 (Type D
personality)
(Denollet, 2005)
Irritability Irritability (4) Do you blow
up more easily
than before?
(12) Do little
things irritate
you more lately
than they used
to? (13) Do
minor hassles
irritate you
more easily the
last few
months?
(17)
Irritability
(1) I was
bothered by
things that
usually don’t
bother me
(5) I am often
irritated
Worry or
anxiety
(10) I felt
fearful
(1) How much
does your
illness affect
your life? (6)
How concerned
are you about
your illness?
(14) Relaxed (2) I often make
a fuss about
unimportant
things. (12) I
often find
myself worrying
about
something
16
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Table 2 (Continued)
Symptom
type
assessed by
interviews
or scales
DSM-IV
Major
Depressive
Disorder
(American
Psychiatric
Association,
2000)
ICD-10 (Mild,
moderate or
severe
depressive
episode) (World
Health
Organisation,
1993)
Maastricht
Interview for
Vital
Exhaustion
(Meesters &
Appels, 1996)
BDI!II (Beck
et al., 1996)
Center for
Epidemiological
Studies-
Depression
scale (CES-D)
(Radloff, 1977)
Hospital
Anxiety and
Depression
Scale
(depression
subscale)
(Zigmond &
Snaith, 1983)
Brief-Illness
Perception
Questionnaire
(Broadbent et
al., 2006)
Global Mood
Scale (positive
and negative
affect rated on a
five-point Likert
scale) (Denollet,
1993)
DS-14 (Type D
personality)
(Denollet, 2005)
Other
symptoms
(10) Do you
have the feeling
that you cannot
cope with
everyday
problems as
well as you used
to? (11) Do you
feel you want to
give up trying?
18) Do you
shrink from
your regular
work as if it
were a
mountain to
climb? (21) Do
you feel
defeated or
disillusioned?
(14) I felt
lonely. (15)
People were
unfriendly.
(19) I felt that
people disliked
me
(3) How much
control do you
feel you have
over your
illness? (5)
How much do
you experience
symptoms
from your
illness? (7)
How well do
you feel you
understand
your illness? (9)
Please list in
rank-order the
three most
important
factors that
you believe
caused your
illness
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Table 2 (Continued)
Symptom
type
assessed by
interviews
or scales
DSM-IV
Major
Depressive
Disorder
(American
Psychiatric
Association,
2000)
ICD-10 (Mild,
moderate or
severe
depressive
episode) (World
Health
Organisation,
1993)
Maastricht
Interview for
Vital
Exhaustion
(Meesters &
Appels, 1996)
BDI!II (Beck
et al., 1996)
Center for
Epidemiological
Studies-
Depression
scale (CES-D)
(Radloff, 1977)
Hospital
Anxiety and
Depression
Scale
(depression
subscale)
(Zigmond &
Snaith, 1983)
Brief-Illness
Perception
Questionnaire
(Broadbent et
al., 2006)
Global Mood
Scale (positive
and negative
affect rated on a
five-point Likert
scale) (Denollet,
1993)
DS-14 (Type D
personality)
(Denollet, 2005)
Social
inhibition
(13) I talked
less than usual
(16) Sociable (1) I make
contact easily
when I meet
people. (3) I often
talk to strangers.
(6) I often feel
inhibited in social
interactions. (8) I
find it hard to
start a
conversation. (10)
I am a closed
kind of person.
(11) I would
rather keep
other people at a
distance. (14)
When socialising,
I do not find the
right things to
talk about
AQ2 Note: DSM-IV-TR. Five or more symptoms during the same two-week period, at least one symptom being depressed mood or anhedonia. ICD differentiation between
mild, moderate and severe. Mild: at least two of main symptoms, plus at least two others (present for at least two weeks). Moderate: at least two of the main symptoms,
plus at least three (preferably four) of the other symptoms. Severe: all three of the typical symptoms, plus at least four other symptoms. Considerable distress/agitation,
unless retardation is a marked feature. Some items may be negatively scored. The following symptom clusters have been strongly associated with increased cardiovascular
risk in adjusted analyses: depressed mood; anhedonia; fatigue; hopelessness; social inhibition.
18
F
.
D
oyle
et
al.
C
:/3B
2W
IN
/tem
p
files/R
H
P
R
304800_S
100.3d
[x]
T
u
esd
ay,
25th
M
arch
2008
18:35:56
UN
CO
RR
EC
TE
D P
RO
OF
and more negative scores on the consequences subscale. In terms of the IPQ
causation subscale, currently depressed women were significantly more likely to
endorse a self-blame item (‘My illness is largely due to my own behaviour’). This item
may be important for establishing a link between depression and illness cognitions.
A recent cross-sectional study investigated associations between illness percep-
tions, depression and gender in 661 patients with ACS (Grace, Krepostman, et al.,
2005). For women, higher levels of depressive symptoms were related to perceiving a
chronic timeline, whereas for men more depressive symptoms related to perceiving a
chronic timeline, more negative consequences, and lower cure/control (Grace,
Krepostman, et al., 2005). Furthermore, those who believed that psychological
factors, such as stress or personality, caused their ACS were more likely to be
depressed. Illness perceptions accounted for a significant variation in depressive
symptoms in this study, but prospective studies are needed to investigate whether
these differences in perceptions reflect poorer outcomes in the depressed ACS
population.
Associations with CHD
The validity of the SRM, or any model, in CHD depends on its ability to predict
illness outcomes and/or behaviours. Investigation of the SRM has provided some
very interesting findings in samples with CHD. Illness perceptions have been
particularly successful in predicting psychosocial outcomes, such as return to work
and quality of life (Broadbent et al., 2006; French et al., 2005; Petrie, Weinman,
Sharpe, & Buckley, 1996). However, results of studies with large sample sizes have
been contradictory, indicating that further work is needed to clarify this area.
Theorists suggest that illness severity should affect illness cognitions, i.e., more
symptoms or more severe symptoms should lead to stronger illness identity (Moss-
Morris et al., 2002; Weinman et al., 1996). However, this may not apply if patients’
perceptions of illness are inaccurate and do not match object measures of disease
severity (Frostholm et al., 2005, 2007). One large prospective survey of CHD patients
has shown that the most important correlate of illness perceptions was disease
severity, and disease severity also predicted illness perceptions at one-year follow-up
(Aalto, Heijmans, Weinman, & Aro, 2005). However, this study showed that all
cognitive illness perceptions were associated with disease severity, not just illness
identity, which may also have implications for depressive cognitions and disease
severity.
Weinman et al. (1996) demonstrated that the IPQ had predictive validity for a
sample of 143 patients with MI. Three- and six-month outcomes were predicted by
various illness perceptions, including self-rated health, self-ratings of risk of further
MI, self-ratings of control of heart problems, and number of doctors’ visits. A meta-
analysis of eight studies of 906 patients demonstrated that four illness perceptions
predicted cardiac rehabilitation attendance (French et al., 2006). Patients with MI
who viewed their condition as controllable, as symptomatic, and with severe
consequences, and who felt that they understood their condition were more likely
to attend. However, study effect sizes were small (r#0.081"0.123).
Weinman, Petrie, Sharpe, and Walker (2000) demonstrated that if patients
believed that lifestyle variables were the causal factors in their MI, then these patients
were more likely to adopt recommended behavioural changes. However, not all
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studies have shown significant associations between illness perceptions and
behaviours in CHD patients. Byrne, Walsh and Murphy (2005) conducted a large
cross-sectional study of 35 randomly selected general practices, sampling patients
with established CHD (n#1084). Illness perceptions and self-report lifestyle factors
(e.g., smoking, exercise, diet) were assessed. Illness perceptions appeared to be poor
predictors of these behaviours, accounting for only 2% of the variance. One distinct
aspect of this research was that illness perceptions were assessed during the chronic
phase of illness (mean duration since diagnosis was seven years), whereas most IPQ
research has focused on cardiac patients during acute phases, e.g., post-MI. To date,
no study has identified whether illness perceptions are differentially associated with
cardiovascular risk. Prospective studies are needed to determine the relationship
between illness perceptions, depression and cardiovascular risk.
Interventions
Although illness perceptions may be inconsistent predictors of health outcomes in
CHD, this area of research has already demonstrated promise regarding interven-
tions to reduce morbidity. A randomised controlled trial has shown that an
intervention based on illness perceptions could modify medical outcomes (angina
frequency) in cardiac rehabilitation patients (Petrie et al., 2002). This study examined
whether a brief hospital intervention designed to alter patients’ perceptions about
their MI would result in a better recovery and reduced disability. Sixty-five patients
with a first MI were assigned to receive the intervention or usual care from
rehabilitation nurses. At three-month follow-up, the intervention resulted in
significant positive changes in patients’ views of their MI. Of importance however,
patients in the intervention group (14.3%) were significantly less likely than control
subjects (39.3%) to report angina pain at three months. Furthermore, the difference
was not due to cardiac rehabilitation attendance, as attendance did not differ
significantly between groups. This study provides evidence for the effect of
psychosocial interventions on morbidity outcomes. The results need to be replicated,
and the effects of other psychosocial outcomes (such as the potential interaction with
depressive symptoms) need to be assessed in larger trials.
Associations between illness cognitions and depression suggest that there could
be a relationship between poorer coping in depressed CHD patients and specific
illness cognitions. Significant associations between the two may point to potential
interventions, as one mechanism by which depression increases cardiovascular risk
may be through poorer adherence to recommendations provided in secondary
prevention (Carney, Freedland, Miller, & Jaffe, 2002; Ziegelstein et al., 2000). Thus,
depression may interact with illness perceptions to further attenuate adherence to
medical advice.
Positive emotion
Considering depression as a categorical disorder may be less useful than one which
considers a spectrum of well-being, from depression to positive mental health
(Keyes, 2004, 2005; Seligman & Csikszentmihalyi, 2000; Seligman, Parks, & Steen,
2004). There is now a more general research drive focusing on ‘positive psychology’:
consideration of positive aspects of human capacity and function and their effects on
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health and other outcomes, rather than simply addressing those who have
pathological negative emotional states (Keyes, 2004; Seligman & Csikszentmihalyi,
2000; Seligman et al., 2004). In this way, positive psychology attempts to address a
perceived imbalance in research that has hitherto focused largely on understanding
and treating suffering. Research in this area can help identify the skills for coping
well with life, and teach these skills to those who do not cope so well. Positive
emotion has been identified as one of the core constituents of happiness (Seligman et
al., 2004). However, a significant limitation in the positive emotion literature is that
there is no widely accepted definition of what constitutes positive emotion, and
several studies confound positive emotion with a related construct, optimism
(Pressman & Cohen, 2005; Russell & Carroll, 1999). Table 2 contains items from
the Global Mood Scale (GMS) (Denollet, 1993), which was developed to assess both
positive and negative mood in cardiac populations, and has been shown to be
responsive to change after cardiac rehabilitation (Hevey, McGee, & Horgan, 2004).
The positive items generally assess energy, relaxation and sociability. These seem to
be the opposite of the fatigue items (this is discussed further in the section on vital
exhaustion). However, there is some debate in the literature about whether positive
emotion is truly the opposite of negative emotion, or whether it is orthogonal (i.e.,
bivariate). Most researchers favour a bivariate explanation (Pressman & Cohen,
2005; Russell & Carroll, 1999).
A recent theory of positive emotions hypothesises an important role for
positive affect in terms of the potential benefit in treating negative emotion.
Fredrickson (1998, 2001, 2002) proposed the ‘broaden-and-build’ theory, and treats
positive emotions as separate to negative emotions (i.e., as bivariate). She states
that positive emotions broaden an individual’s momentary thought!action
repertoires, and consequently build the individual’s enduring personal resources,
which then lead to better coping with subsequent life events. An example is
interest, which compels us to investigate our surroundings and develop our current
knowledge (Fredrickson, 2002). A possible example of interest in cardiac patients
which could be beneficial would be a patient reading all provided leaflets about
their illness, perhaps even finding more information on the internet, and then
closely following the advice for dietary change and increased exercise. Negative
emotions narrow a person’s thought!action repertoire (e.g., phobia: a person may
feel very anxious in a given situation or when exposed to an anxiety-inducing
stimulus, and can barely think beyond escaping the situation or stimulus), whereas
positive emotions broaden this array of possible behaviours. Another important
aspect of this theory is that personal resources acquired in this way are thought to
have strong durability, and these resources outlast the positive states that induced
them (Fredrickson, 2002). They can subsequently be drawn upon in later
experiences, and through this method, the individual can transform themselves
(i.e., becoming more knowledgeable, sociable, etc.). This then leads to an upward
spiral of positive affect (see Figure 1). An important hypothesis of this theory is
that positive emotions ‘undo’ the effects of negative emotions (Fredrickson, 2002) !
which may be significant in terms of negative emotions and increased cardiovas-
cular risk.
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Just as depression has been associated with negative health outcomes, positive
emotions are associated with favourable health outcomes in several disease types
(Keyes, 2004; Maruta, Colligan, Malinchoc, & Offord, 2000; Ostir, Markides, Black,
& Goodwin, 2000; Ostir et al., 2001a; Ostir et al., 2002; Ostir, Ottenbacher, &
Markides, 2004). The prevalence of cardiovascular disease was lowest among those
who were mentally healthy (defined as flourishing), but highest among those who
were depressed and languishing (devoid of well-being but not depressed), in a study
of over 3000 adults (Keyes, 2004). This suggests a protective role for positive emotion
in medical patients.
This protective role of positive emotion has been demonstrated in aetiological
studies and CHD samples (Kubzansky, Sparrow, Vokonas, & Kawachi, 2001; Ostir,
Peek, Markides, & Goodwin, 2001b; Scheier et al., 1989, 1999). A 10% reduced risk
of incidence of MI per unit increase of positive emotion scores has been
demonstrated in older adults, even when controlling for negative affect (Ostir
et al., 2001b). Although this study can be criticised for using a depression
questionnaire to assess positive affect, previous work has demonstrated that the
scale used (Center for Epidemiological Studies ! Depression scale: CES-D)
subdivides into positive and negative emotion items (e.g., Miller, Markides, &
Black, 1997; Sheehan, Fifield, Reisine, & Tennen, 1995). The items of the CES-D can
be seen in Table 2, and four positive emotion items that load together are: ‘I felt that
I was just as good as other people’, ‘I felt hopeful about the future’, ‘I was happy’,
and ‘I enjoyed life’. A 10-year prospective study of optimism and CHD incidence in
1306 men showed that those with high levels of optimism had a 55% reduced risk of
cardiovascular morbidity or mortality in adjusted analysis when compared to those
with high pessimism levels (Kubzansky et al., 2001). Also of significance was the
reported dose!response relationship between optimism and outcomes, which has
parallels with similar (but opposing) results with depression outlined previously (Lett
et al., 2004; Rugulies, 2002).
Positive and depressive emotion ratings were assessed in 866 cardiac catheterisa-
tion patients as predictors of survival over a mean follow-up of 11.4 years (Brummett
et al., 2005). Positive and depressive scores were associated with increased and
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Transform individuals and produce upward spirals
Build enduring personal resources
Broaden momentary though-action repertoire
Experience positive emotion
Figure 1. The Broaden-and-Build Theory of positive emotion (Fredrickson, 1998, 2001,
2002).
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decreased survival, respectively. Interestingly, however, when positive and depressive
scores were analysed together, positive emotions were no longer statistically
significant (Table 1). This suggests that although positive emotions are important,
they may have lesser significance than depressive symptoms in CHD prognosis
during the acute phase. However, although positive emotions may not have an
immediate impact, over time it is possible that they could reduce the impact of
negative affect. This may be important in cases where increased chronic negative
affectivity is present, rather than episodic bouts of negative affect. Further
prospective studies are needed to address this possibility, and determine the relative
contribution of positive and negative affect to outcomes.
Interventions
Interestingly from a cardiovascular perspective, positive emotions are thought to
negate the lingering effects of negative emotions. This is thought to work through the
broadening mechanism ! an individual’s repertoire cannot narrow and broaden at
the same time (Fredrickson, 2002). Positive interventions have been shown not only
increase happiness, but also to decrease depression (Brown & Ryan, 2003; Fava,
Rafanelli, Cazzaro, Conti, & Grandi 1998; Fava & Ruini, 2003; Seligman, Steen,
Park, & Peterson, 2005). Positive psychology has already proved valuable in
formulating strategies in managing affective disorder in cancer patients (Brown &
Ryan, 2003). The efficacy of several brief interventions has been demonstrated
previously (Seligman et al., 2005). One intervention that was shown to increase
happiness and decrease depressive symptoms for six months involved participants
writing down three things that went well each day (and their causes) for one week
(reported effect size#0.5 at six months) (Seligman et al., 2005). Although these
interventions have shown efficacy for reducing depression, they have not been tested
in the CHD population. The measurement of positive emotion in CHD patients
could provide useful models for patient management by helping to define the
characteristics of those at lowest risk. Future studies could use both validated
positive and negative measures of well-being to capture the spectrum of psycholo-
gical adaptation. It may be that positive emotions are useful for treating depressive
symptoms, but also protective of subsequent cardiovascular morbidity and mortality.
If this is the case, then the introduction of positive psychology interventions may
provide a promising alternative to an outright focus on negative emotions such as
depression.
Vital exhaustion
Some psychological constructs have been specifically developed in the cardiac
population. Vital exhaustion is characterised by feelings of excess fatigue, energy
loss, irritability and demoralisation, which appear unrelated to (cardiac) illness
severity (Appels, 2004; Appels, Hoppener, & Mulder, 1987; Appels & Mulder, 1989).
Several of these symptoms are similar to somatic symptoms of depression, and some
authors have therefore stated that vital exhaustion has poor content validity
(McGowan et al., 2004). Table 2 contains the 23 questions from the Maastrict
Interview for Vital Exhaustion. Comparing these with DSM-IV symptoms of
depression, 14 questions for vital exhaustion could be argued to overlap with DSM-
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IV symptoms. Furthermore, 19 of these questions could overlap with the ICD-10
classification of depression (which differs from the DSM-IV classification in that it
includes symptoms of anergia, hopelessness and irritability). The level of overlap
between depression and vital exhaustion requires further clarification. One main
difference may be that vital exhaustion does not seem to measure anhedonia (apart
perhaps from one item on sex). This may be crucial as anhedonia has specifically
been linked to increased cardiovascular risk (Doyle et al., 2006). Furthermore, vital
exhaustion appears to have substantial overlap with positive and negative emotion
(as characterised by the GMS and assuming that positive/negative emotion is a
univariate construct), with 14 vital exhaustion items corresponding to 18 GMS items
(Table 2). This then leads to the intriguing question ! is vital exhaustion a marker for
lack of positive affect (or vice versa)? Studies assessing an association between vital
exhaustion and depression have shown that the constructs are highly correlated
(Kopp, Falger, Appels, & Szedmak, 1998; McGowan et al., 2004; Wojciechowski,
Strik, Falger, Lousberg, & Honig, 2000). However, it is unclear whether research in
this area measures overlapping symptoms of depression and vital exhaustion, or
whether the unique symptoms of exhaustion are more important. Three main factors
have been identified ! fatigue, depressive symptoms and irritability (Appels, Kop, &
Schouten, 2000). Fatigue may therefore have a significant role (but perhaps different
role to depression) in outcomes in those with CHD (McGowan et al., 2004),
although some researchers report that somatic symptoms of depression are less
relevant for risk prediction than depressed affect (Barefoot et al., 2000; Carney &
Freedland, 2003).
Associations with depression and CHD
Several studies have shown that vital exhaustion is a precursor for cardiovascular
morbidity and mortality in otherwise healthy individuals (Appels, 2004; Appels et
al., 2000; Appels & Mulder, 1988, 1989; Bages, Appels, & Falger, 1999; Falger &
Schouten, 1992). Appels and Mulder (1988) showed that vital exhaustion increased
the risk of MI by 150% in a study of 3877 civil servants followed for four years.
McGowan et al. (2004) investigated the association between depression and vital
exhaustion in 305 first MI patients. Depression was highly correlated (r#0.61) with
vital exhaustion, but the constructs loaded separately in factor analysis. However,
these authors used a depression scale which did not measure somatic symptoms of
depression (i.e., the Hospital Anxiety and Depression Scale (Zigmond & Snaith,
1983) ! see Table 2). Therefore, it is not surprising that the constructs were not found
to load onto one factor. Other researchers failed to provide support for separate
constructs of vital exhaustion and depression (Wojciechowski et al., 2000).
A study on the impact of depression and fatigue on outcomes following MI
showed that either variable was associated with sudden cardiac death, however when
both variables were included in analysis, fatigue moderated the influence of
depression (Table 1) (Irvine et al., 1999). Fatigue has also been demonstrated to
have the strongest predictive power for incident MI, but the predictive power of
depression and irritability was eliminated when controlling for fatigue (Appels et al.,
2000). Vital exhaustion may therefore be useful to identify those with fatigue, but
without depression, or it may also be an alternative marker of disease severity or
comorbidity (McGowan et al., 2004). Vital exhaustion prior to MI has also been
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shown to be more important for developing subsequent depression, than depression
prior to the acute event (Spijkerman, van den Brink, Jansen, Crijns, & Ormel, 2005).
Notably, no studies with CHD samples have shown that vital exhaustion predicts
outcomes for longer than five years (Table 1). It is possible that exhaustion may be
better considered in terms of a short- to medium-term risk prediction, and that
differing mechanisms may be involved in shorter-term (e.g., physiological) and
longer-term (e.g., behavioural) outcomes. Longer-term assessments of vital exhaus-
tion and depression in CHD samples are needed.
Interventions
A short behavioural intervention (combined stress-management and health educa-
tion programme during eight weekly 2.5 h sessions) was evaluated in an effort to
alter vital exhaustion and depression in patients with CHD (Sebregts, Falger, Appels,
Kester, & Bar, 2005). The intervention failed to modify either vital exhaustion or
depression during the nine-month follow-up, possibly due to a significant reduction
in post-event major depression seen in the control group (Sebregts et al., 2005). A
similar outcome for controls was also seen in the ENRICHD trial. Further research
showed that although angina symptoms were related to vital exhaustion in patients
scheduled for coronary angiography, a reduction in angina frequency did not lead to
a reduction in vital exhaustion scores (Pedersen & Middel, 2001). These results
suggest that vital exhaustion may not be amenable to intervention to reduce
associated morbidity.
However, some results have suggested that a reduction in vital exhaustion may
indeed reduce morbidity in patients with CHD (Appels, 2004; Appels, Bar, Lasker,
Flamm, & Kop, 1997). A randomised controlled trial of an intervention designed to
reduce vital exhaustion and morbidity (EXIT) was conducted on 710 patients
undergoing percutaneous coronary intervention (Appels, 2004; Appels et al., 2005).
The treatment aimed to identify and reduce stressors and make rest more efficient
through group discussions. Recovery was promoted by discussing length of resting
time, by doing relaxation exercises and by stimulating physical exercise. After 18
months, the intervention group had a 55% reduced risk of being exhausted and a
53% reduced risk of being depressed. Anginal complaints were reduced by 29%.
However, no difference in recurrent coronary events was seen. A post-hoc analysis
(eliminating events that occurred before or during the intervention) showed that the
risk of a further coronary event was reduced by 55%, but that patients with a history
of CHD did not benefit. These results provide some support for the intervention.
However, replication is needed due to the methodology (vitally exhausted patients
were selected, therefore generalisability is questionable) and the overlap between
depression and vital exhaustion. It is interesting that the patients in this trial also
showed a reduction in depression. The concept of vital exhaustion is not
theoretically derived, therefore it may be difficult to pinpoint effective interventions
and to differentiate these interventions from similar interventions for depression.
Type D personality
One particular area of research focuses on distress in the cardiac population and how
individuals deal with this distress. This area has addressed personality in order to
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explain the tendencies to experience negative emotions and thus heighten cardio-
vascular risk. Type D (distressed) personality is based on the stable traits of negative
affectivity and social inhibition, which reflect tendencies to experience increased
negative distress across situations and to then inhibit the expression of these
emotions in social settings (for fear of rejection or disapproval ! see Table 1)
(Denollet, 1998a, 2000, 2005; Denollet & Van Heck, 2001; Pedersen & Denollet,
2003). Previously, it has been questioned whether Type D personality really
constituted anything different to negative emotion states such as depression, whether
it can account for the risk associated with these states, or whether it simply congests
a complex field of multiple psychological ‘risk factors’ (Carney, 1998; Lesperance &
Frasure-Smith, 1996). The DS-14 questionnaire items listed in Table 2 demonstrates
that although negative affectivity of course overlaps with depressive symptoms, the
social inhibition aspect of Type D is very different. Four items seem to assess trait
depressed mood, and another item assesses irritability (which is assessed by ICD-10).
Two negative affectivity items that differentiate Type D from depression (i.e., are not
assessed by either DSM-IV or ICD-10 criteria for depression) are anxiety/worry.
Thus, not only does Type D assess trait (instead of state) negative mood, it also
incorporates some symptoms of anxiety/worry and the unique aspect of social
inhibition. Type D is stable over a period of at least 18 months, and has been shown
to be unaffected by changes in depression or anxiety states (Denollet, 2005; Martens,
Kupper, Pedersen, Aquarius, & Denollet, 2007). The developers also propose that
the Type D disposition is grounded in personality theory, and therefore reject
criticism which questions its construct validity in terms of its comparison to
depressive or anxiety states (Denollet & Van Heck, 2001).
Associations with depression and CHD
Type D has been associated with increased depressive symptoms in several studies
(Denollet & Brutsaert, 1998; Denollet, Pederson, Ong, et al., 2006; Denollet et al.,
1996), and has also been shown to be associated with other constructs related to
cardiovascular outcomes, such as vital exhaustion (Pedersen & Denollet, 2003;
Pedersen & Middel, 2001). Assessment of vital exhaustion and Type D personality in
cardiac patients showed that those with a Type D disposition were likely to have a
high vital exhaustion score (Pedersen & Middel, 2001). These associations are
perhaps unsurprising as some theorists postulate that a general predisposition to
negative affectivity makes individuals more prone to episodic phases of strong
negative emotions, such as depression (Suls & Bunde, 2005).
However, the growing importance of Type D personality in the cardiovascular
sphere is highlighted by research which shows it to be an independent risk factor for
cardiovascular morbidity and mortality (Table 1) (Denollet, 1998b; Denollet &
Brutsaert, 1998; Denollet, Sys, & Brutsaert, 1995; Denollet et al., 1996; Denollet,
Vaes, & Brutsaert, 2000; Pedersen & Middel, 2001). For example, Type D was an
independent predictor of cardiac morbidity and mortality at five years follow-up of
319 patients with established CHD, even when controlling for standard cardiovas-
cular risk factors (Denollet et al., 2000). A review of ten articles investigating the
Type D construct in cardiac patients showed that those with Type D personality were
at increased risk for fatal and non-fatal cardiovascular events, with odds-ratios
(ORs) ranging from 4.1 to 8.9 (Pedersen & Denollet, 2003). These large effect sizes
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emphasise the importance of research in this area, and the authors conclude that
how individuals cope with negative emotions (inhibition) may be an important
mechanism of action that differentiates Type D from studies of negative emotions.
Importantly, several studies have shown that Type D personality contributes to
cardiovascular morbidity and mortality over and above the risk associated with other
constructs such as depression and anxiety (Denollet & Brutsaert, 1998; Denollet,
Pederson, Ong, et al., 2006; Denollet et al., 1996; Pedersen & Denollet, 2003). In
studies which measured both depression and Type D, results showed that Type D
remained the strongest psychological predictor of outcomes (Denollet & Brutsaert,
1998; Denollet, Pederson, Ong, et al., 2006; Denollet et al., 1996). Depression even
became non-significant in some studies (Table 1) (Denollet & Brutsaert, 1998;
Denollet, Pederson, Ong, et al., 2006). Social inhibition may in fact be the crucial
aspect of risk prediction. Denollet, Pederson, Ong, et al. (2006) analysed major
cardiac endpoints (death, MI, coronary artery bypass graft (CABG), or PCI) at nine
months in a sample of 875 percutaneous coronary intervention patients. Patients
completed the HADS and the DS-14, six months post-PCI. Analysis of the major
cardiac events showed that the prevalence of such events was significantly higher in
those with high negative affectivity and high inhibition (15%) compared with the
group with high negative affectivity and low social inhibition (10%), Furthermore,
the moderating effect of inhibition was not explained by either depression or anxiety.
From these results, it is clear that Type D is not just another measure of general
distress or depression. As Type D is a disposition rather than a state, it may
potentially have both short- and long-term effects on risk, over and above that of
negative emotional states (which would theoretically benefit from intervention).
Aetiological studies are needed to assess whether Type D confers risk for the
development of CHD in healthy individuals.
Interventions?
It is questionable whether having a negative personality type lends itself to
interventions to reduce negative emotions. Relatively short behavioural interventions
designed for mood change may have little efficacy against a stable personality
disposition, although it is possible that Type D patients could benefit (but not to the
extent that non-Type D patients would benefit) (Pedersen & Denollet, 2003). It may
be that Type D personality best accounts for the associated psychological risk factors
outlined above. This construct may also explain the failure of some of the
interventions outlined previously. Unless intervention studies attempt to control
for this personality disposition, the efficacy of interventions may be limited.
However, as social inhibition may be the crucial determinant of increased risk in
those displaying the Type D disposition, this may prove a fruitful avenue for
intervention. As outlined previously, an increase in positive affect may increase
personal resources and social interaction, which then lead to better coping with
subsequent life events (Fredrickson & Joiner, 2002). Thus, one could speculate that
social inhibition might be gradually eroded by an increase in positive emotions and
the upward spiral of positive affect. Of significance here are the previously outlined
findings demonstrating that high negative affect was unimportant for cardiovascular
risk prediction when social inhibition is low (Denollet, Pederson, Ong, et al., 2006).
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Hypothetically, positive emotion interventions deserve consideration for a reduction
in social inhibition.
Future directions
The present paper provides an overview of constructs related to increased
cardiovascular risk, and assesses their potential for intervention. Based on the
accumulating evidence, it is questionable whether depressive cognitions are as
important as previously considered, as they do not seem to be associated with clinical
outcomes and intervention did not demonstrate risk reduction. Intriguingly, there
may be some potential for designing interventions based on distorted illness
cognitions. However, the interaction between illness and depressive cognitions needs
to be formally assessed, and illness cognitions have yet to be established as consistent
predictors of clinical outcomes. Somatic symptoms of depression and fatigue may be
more important aspects for associated risk, however, interventions have also failed to
reduce morbidity. An important confounder for consideration is the Type D
personality disposition. Type D may influence research findings via two mechanisms
! a general disposition to negative affectivity, and the modulating aspect of social
inhibition. Measurement of positive affect could provide clues on how to intervene in
negative emotions in this population, and studies from other populations provide
some hope for positive emotion interventions. Thus, despite accumulating evidence
over almost 30 years, there remain significant challenges in this field.
The first challenge is one of significant overlap between constructs. For example,
it can be argued that depressed mood is assessed by each of the constructs outlined in
the paper (Table 2). This overlap raises several possibilities. First, one construct (e.g.,
depression) or symptom (e.g., anhedonia) is most pertinent for increased risk, and
the positive associations found in other research occurs as a result of high correlation
between this pertinent construct/symptom and the other perhaps less important
aspects. Previously, researchers have stated that depression is a heterogeneous
disorder with several differing symptoms, thus assumptions of the homogeneity of
depression in the cardiac population needs to be considered as one explanation for
the failure of interventions (Davidson, Rieckmann, & Rapp, 2005; Frasure-Smith &
Lesperance, 2003; van Melle et al., 2007). A first step in assessing this is discovering
which symptom or cluster of symptoms is most relevant for cardiovascular risk.
Therefore, large studies powered to assess all of these relevant variables are required.
We thus echo the call of other researchers who recommend that researchers re-
analyse their datasets and perhaps even pool datasets to allow for more powerful
latent variable analysis (Davidson et al., 2005; Suls & Bunde, 2005), in order to
address the increased risk of individual symptoms. Once the most pertinent
symptom/construct is identified, then interventions could be targeted more
efficiently. Failure to identify the most relevant symptoms or constellation of
symptoms that increase (or decrease) cardiovascular risk may reduce the efficacy of
future interventions.
Another alternative is that depression, or other constructs, assessed post-event
are actually a proxy measurement of some (perhaps undefined) psychosocial
construct that does contribute to poorer clinical outcomes. For example, all these
constructs may tap a common underlying latent variable, such as a disposition
towards negative affectivity, and this latent variable may be the factor that increases
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risk (Suls & Bunde, 2005). To date, researchers have assumed that negative emotions
are independent, and that the effects of these emotions are also independent (Suls &
Bunde, 2005). This hypothesis could explain the heterogeneity of findings of various
negative emotion constructs and increased risk. The present review clearly outlines
that there is substantial measurement and construct overlap. Thus, more sophisti-
cated analysis of such studies is required.
A second challenge concerns the potential for intervention. To date, studies on
depression have been largely atheoretical, providing no real insight into how
interventions may be derived from their findings. To our knowledge, only one study
has demonstrated that several theoretical vulnerabilities to depression are present in
the depressed cardiac population. Rieckmann et al. (2006) assessed 314 ACS patients
with the BDI within one week of hospital admission and reported that both mildly
and moderately/severely depressed patients showed higher levels of cognitive,
interpersonal and behavioural vulnerabilities. These vulnerabilities independently
contributed to depressive symptoms (although the presence of more than one
vulnerability increased the odds of being depressed). What may be interesting in the
context of the current review is whether depressive symptoms were qualitatively
different across those with different vulnerabilities, i.e., are specific vulnerabilities
more important for anergia or anhedonia? Furthermore, it would be important to
follow patients demonstrating these vulnerabilities to determine which vulnerability-
caused symptoms (or symptom clusters) are most relevant for cardiovascular risk.
This could then allow targeting of potentially risk-reducing interventions. When the
most relevant symptoms, syndromes or interactions are pinpointed, their mechan-
isms of action need to be identified. Additionally, it is possible that some or all
aspects (cognitions, emotions, fatigue and personality) could combine synergistically
to produce higher risk than any single aspect. If this is the case, then interventions
addressing individual constructs are doomed to failure until the overall, interacting
mechanisms are understood.
While the SADHART, ENRICHD and MIND-IT trials showed that a subset of
individuals did not respond to treatment, post hoc analysis has shown that non-
responders and those with incident depression were at greater risk of subsequent
events (Carney et al., 2004; de Jonge, Honig, et al., 2007; Glassman et al., 2002). This
is suggestive of a non-responsive subtype of depression which confers increased
cardiovascular risk, but also that the ‘depression’ is actually triggered by the event
itself. This raises questions on the extent that depression existed prior to the event,
whether ‘depression’ is simply a marker of disease severity (for those with incident
depression), and to what extent pre-existing depression and incident depression
confer increased risk. Previous work has demonstrated that ‘depression’ in CHD
patients is mostly made up of somatic symptoms (Luutonen, Holm, Salminen, Risla,
& Salokangas, 2002; Sorensen et al., 2005). There is also the suggestion that somatic
symptoms may be cardiotoxic, whereas cognitive-affective symptoms are not (de
Jonge, van den Brink, Spijkerman, & Ormel, 2006). Incident depression post-ACS
has been shown to be related to more severe CAD (Goodman, Shimbo, Haas,
Davidson, & Rieckmann, in press; Spijkerman, de Jonge, et al., 2005), and is more
cardiotoxic than other depression subtypes (de Jonge et al., 2006; Grace, Abbey, et
al., 2005). This suggests that somatic symptoms such as fatigue may be markers of
underlying disease severity or prodromal states. If this is the case, then this could
explain the findings regarding vital exhaustion and other somatic symptoms of
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depression. However, it would not explain the studies which showed an association
between cognitive/affective symptoms and outcomes (Barefoot et al., 2000; Carney &
Freedland, 2003; Lesperance, Frasure-Smith, & Talajic, 1996), or the association
between positive emotion and outcomes. Furthermore, aetiological studies have
established an association between depressive symptoms and incident CHD in
initially healthy individuals, as demonstrated in systematic reviews (Rugulies, 2002;
Wulsin & Singal, 2003). The findings of Rieckmann et al. (2006) outlined above,
which show that depressed ACS patients exhibit the theoretical vulnerabilities to
depression, also indicate that depression is present prior to the cardiac event in a
substantial number of patients. As these vulnerabilities would have been present
prior to the ACS event, and they are theoretically unrelated to CHD, one could
therefore argue that these patients are depressed independently of CHD severity.
Future studies need to differentiate pre-event depression from incident depression to
determine the relative contribution of different subtypes to increased risk. The
potential for intervention will hinge on the identification of the cardiotoxic subtypes
or symptoms of depression.
Other researchers have highlighted issues of sample size, lack of efficacy of
interventions for depression, under-use of appropriate disease severity indices,
inflation of effect sizes of depression (and consequent overestimation of potential for
intervention), heterogeneity of depressive symptoms, common genetic pathways for
depression and CHD, physiological mechanisms and lack of studies pinpointing
precise mechanisms (Carney & Freedland, 2007; Davidson et al., 2005; Frasure-
Smith & Lesperance, 2003; Lane, Carroll, Ring, Beevers, & Lip, 2001; McCaffery et
al., 2006; Nicholson et al., 2006; Skala, Freedland, & Carney, 2006; van Melle et al.,
2007). The appropriate assessment of CHD severity indices and the subsequent
inflation of effect sizes for depression require further exploration. Nicholson et al.
(2006) concluded that depression has yet to be established as an independent risk
factor for CHD because of non-adjustment for conventional risk factors and severity
of coronary disease. In their systematic review of 34 prognostic studies, only eight
reported left ventricular function, and the inclusion of this variable attenuated the
relative risk associated with depression by 48% (from 2.18 to 1.53). Lane and
colleagues have also criticised prognostic studies for imperfect measurement of CHD
risk factors, which may lead to under-adjustment in multivariate prognostic models,
thereby inflating the effects of depression (Lane, Carroll, & Lip, 2003; Lane et al.,
2004). Indeed, several studies have shown a relationship between depression and
measures of disease severity, including left ventricular function. Of interest here is
that Type D personality does not demonstrate a relationship with somatic health (de
Jonge, Denollet, et al., 2007). Their study assessed Type D status in a sample from
MIND-IT, and showed no relationship with Type D status at one year and baseline
somatic health (including left ventricular ejection fraction, comorbidity index, prior
MI or coronary interventions during hospitalisation). Depression was associated
with comorbidity and left ventricular ejection fraction, and these results further
highlight the potential importance of the Type D construct. Studies need to control
for appropriate disease severity indices, and determine whether the depressive
episode existed pre-event, to ascertain the association between depression and
outcomes.
The present review aimed to summarise the current impasse in moving from
prediction to intervention in the depression and CHD outcomes relationship. A
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number of recent, large, randomised trials have failed to demonstrate the
cardiovascular benefit from psychological or pharmacological interventions in
cardiac patients. There is certainly the danger that the wider medical community
decide that this topic is concluded and that research funds will be increasingly
difficult to commandeer in the future. In this regard, we see our review as somewhat
a ‘call to arms’ for the Health Psychology community. We need to demonstrate that a
more sophisticated understanding of these issues can lead to more precise
pinpointing of the ‘cardiotoxic’ aspects of psychological status and interventions
that are more refined to address these. The second aim of this review was to provide
a single inclusive report of the psychological concepts relevant to depression and
cardiovascular outcomes. There is much construct overlap in the negative emotions
literature; positive emotions have been relatively neglected in cardiac populations;
there is the challenge of designing interventions without knowledge of precise
mechanisms; and there is atheoretical assessment of depression and related
constructs in the field. The challenge is for psychological research to provide clarity
on these issues ! overlapping and priority constructs; the faithful translation of
constructs into interventions; and controlling where necessary for psychological
constructs that are relatively immutable risk factors. To do this, researchers must
seek to integrate across concepts, methods and studies.
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